InvestorsObserver
×
News Home

Does Arcutis Biotherapeutics Inc (ARQT) Have What it Takes to be in Your Portfolio Monday?

Monday, April 01, 2024 10:05 AM | InvestorsObserver Analysts

Mentioned in this article

Does Arcutis Biotherapeutics Inc (ARQT) Have What it Takes to be in Your Portfolio Monday?

A rating of 82 puts Arcutis Biotherapeutics Inc (ARQT) near the top of the Biotechnology industry according to InvestorsObserver. Arcutis Biotherapeutics Inc's score of 82 means it scores higher than 82% of stocks in the industry. Arcutis Biotherapeutics Inc also received an overall rating of 71, putting it above 71% of all stocks. Biotechnology is ranked 18 out of the 148 industries.

Overall Score - 71
ARQT has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on ARQT!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 71 would rank higher than 71 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Arcutis Biotherapeutics Inc Stock Today?

Arcutis Biotherapeutics Inc (ARQT) stock is trading at $9.58 as of 10:04 AM on Monday, Apr 1, a decline of -$0.33, or -3.33% from the previous closing price of $9.91. The stock has traded between $9.45 and $10.00 so far today. Volume today is low. So far 571,472 shares have traded compared to average volume of 4,920,106 shares. Click Here to get the full Stock Report for Arcutis Biotherapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App